Founded in 2013, Health2Sync offers digital solutions to help people with chronic diseases, pre-diabetes, or weight concerns to manage their health. 

 The product offerings, including the "Health2Sync App," a "Patient Management Platform," and automated health engagement solutions, are now the largest in Asia of its kind and are proven to help users improve their blood glucose outcomes. 

 The "Health2Sync App helps chronic disease patients easily record their blood glucose level, blood pressure, weight, and lifestyle data such as diet and exercise. Through automated data syncing and analyses, healthcare professionals can view patients' data in the "Patient Management Platform," which also enables them to provide timely personalized interventions by identifying patient situations efficiently, realizing integrated diabetes care. 

 Health2Sync's achievements include being the first approved digital therapeutics in Taiwan for their insulin dosage titration software, Insultrate, which they co-developed with Sanofi. The company has also received the "NEXT BIG" Startup title from the Taiwan National Development Council. With over 1.2 million users worldwide, Health2Sync is Asia's leading chronic disease management platform.